Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06007976 · ClinicalTrials.gov registry record · NA

LLLT to Reduce Low Back Pain

A NA study of Low Back Pain, sponsored by Mayo Clinic.

Active
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06007976: Active NA study of Low Back Pain, sponsored by Mayo Clinic.

NCT06007976 is a NA study of Low Back Pain that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 60 participants, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06007976, a NA study of Low Back Pain, is active but no longer recruiting, sponsored by Mayo Clinic.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to gather information on the effectiveness of the Trident low-level laser therapy (LLLT) in combination with clinical patient education manuals to reduce lower back pain.

Primary Outcome

The PROMIS Numeric Rating Scale v1.0 - Pain Intensity 1a will be used to measure pain intensity on a VAS scale where '0' is no pain and '10' being the worst imaginable pain.

Conditions Studied

Interventions

  • DEVICE Erchonia® Trident

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-02-16
Est. Completion 2026-12
Phase NA
Mayo Clinic

2,844 total trials

What the registry record for NCT06007976 still lists

NCT06007976 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (88% lower).

The record links to 1 condition, with Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which Erchonia® Trident is the first listed.

NCT06007976 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT06007976 about?

NCT06007976 is a clinical study titled "LLLT to Reduce Low Back Pain". The purpose of this research study is to gather information on the effectiveness of the Trident low-level laser therapy (LLLT) in combination with clinical patient education manuals to reduce lower back pain.

What is the current status of trial NCT06007976?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-02-16. Estimated completion is 2026-12.

What conditions does trial NCT06007976 study?

This clinical trial studies the following conditions: Low Back Pain.

What interventions are being tested in trial NCT06007976?

The interventions under investigation include: Erchonia® Trident (DEVICE).

Who is sponsoring clinical trial NCT06007976?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06007976 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06007976's enrollment target sits among peer trials

60 79th of 122 higher than 39 of 122 other Low Back Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06007976, the US trial registry maintained by the National Library of Medicine. NCT06007976 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.